1. Adams JA, Liu Yin JA, Brereton ML, Briggs M, Burgess R & Hyde K (1997) The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on mcgakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukemia.British Journal of Haematology99, 139–146
2. Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H, Nabeshima R, Shima D, Handa H&Toyama K (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro.Leukemia Research23, 239–246
3. Aizawa S, Hiramoto M, Hoshi H, Toyama K, Shima D & Handa H (2000) Establishment of stromal cell line from an MDS RA patient which induced an apoptotic change in hematopoietic and leukemic cell in vitro.Experimental Hematology28, 148–155
4. Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M & Saito H (1994) Growth analysis of marrow CD34-positive hematopoietic progneitor cells in patients with myelodysplastic syndromes.Leukemia8, 833–838
5. Backx B, Broeders L, Hoefsloot LH, Wognum B & Lowenberg B (1996) Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.Leukemia 10466–472